Monthly Archives: January 2012

Research Project's efficient solution for early cancer detection receives Leonardo da Vinci Prize

International philanthropists are challenging the world to provide a Cancer Research Project offering the most efficient solution in Particle Physics for early cancer detection with the highest potential to reduce premature cancer death. Taxol, the trade name of a drug … Continue reading

Posted in Uncategorized | Leave a comment

Bionovo prices public offering of common stock at $1.30 per share

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women’s health and cancer, today announced the pricing of its previously announced underwritten public offering, to sell up to 30,031,200 units at a … Continue reading

Posted in Uncategorized | Leave a comment

FDA reports possible association between breast implants, ALCL

The U.S. Food and Drug Administration reported on January 26 that “a possible association between saline and silicone gel-filled breast implants and anaplastic large cell lymphoma, a very rare type of cancer. Data reviewed by the FDA suggests that patients … Continue reading

Posted in Uncategorized | Leave a comment

North Shore-LIJ seeks patients with early-stage prostate cancer to participate in Phase I study

The North Shore-LIJ Health System Department of Radiation Medicine announced today it is seeking patients with early-stage prostate cancer to participate in a Phase I Research study. A Phase I study establishes the safety of a treatment, and so the … Continue reading

Posted in Uncategorized | Leave a comment

Genetic study helps investigators solve medical mysteries

The mystery began in 1976. Adolfo Pampena was diagnosed with a rare form of cancer that caused a strange combination of symptoms and was associated with the occurrence of multiple tumours in his stomach and colon. His medical team was … Continue reading

Posted in Uncategorized | Leave a comment

U-M researchers reveal molecular signals that regulate catch-up growth

University of Michigan researchers have uncovered molecular signals that regulate catch-up growth—the growth spurt that occurs when normal conditions are restored after a fetus, young animal or child has been ill, under stress or deprived of enough food or oxygen … Continue reading

Posted in Uncategorized | Leave a comment

BioTime announces acquisition of CTI assets

BioTime, today announced that it has acquired substantially all the assets of Cell Targeting, a Cleveland, Ohio-based biotechnology company conducting research in regenerative medicine. "Our acquisition of the assets of CTI is indicative of our plan to assemble a core … Continue reading

Posted in Uncategorized | Leave a comment